Cubist Pharmaceuticals The Shape Of Cures To Come.™
  • About Cubist
  • Products & Pipeline
  • Investor Relations
  • Careers
  • News & Media
  • Search
  • News & Media
  • Cubist in the News
  • Press Releases
  • Background Materials

Upcoming Events

  • 7 Jun
    Cubist Pharmaceuticals Annual Meeting of Stockholders
    Thursday Jun. 7th 2012
  • 11 Jun
    Cubist Pharmaceuticals’ Product Pipeline Investor and Analyst Event
    Monday Jun. 11th 2012
  • 18 Jun
    2012 BIO International Convention
    Monday Jun. 18th 2012
  • View All Upcoming Events

News & Media

Superbugs - The threat is real.

Press Releases View All

  • 5/16/2012
    Cubist Pharmaceuticals Marks 20th Anniversary by Making Its Largest-Ever Commitment to STEM Programs
  • 5/14/2012
    Cubist Announces First Scientific Presentations of Phase 2 Data for CB-5945 in the Treatment of Opioid-Induced Constipation
  • 5/7/2012
    Cubist Pharmaceuticals to Present at May Investor Conference
  • 4/18/2012
    Cubist Pharmaceuticals Reports First Quarter 2012 Financial Results
  • 4/17/2012
    Cubist Announces Positive Results from ENTEREG® Phase 4 Study in Patients Undergoing Radical Cystectomy
  • 4/2/2012
    Cubist Pharmaceuticals to Announce Q112 Financial Results on Wednesday, April 18th, 2012
  • 3/16/2012
    Cubist Opens Expanded Research and Development Facility
  • 3/9/2012
    Cubist Pharmaceuticals Appoints Jane Henney to Board of Directors
  • 2/20/2012
    Cubist Pharmaceuticals to Present at February/March Investor Conferences
  • 2/16/2012
    Cubist Pharmaceuticals Appoints Alison Lawton to Board of Directors

Cubist in the News View All

  • Nothing bugs Cubist CEO Michael Bonney View
    Loyalty, commitment and a cool head saves a money-making drug
  • Cubist-sponsored Battling Superbugs micro site launched View

Media Contact

At Cubist:

Francis McLoughlin
Director, Corporate Communications
(781) 860-8777
francis.mcloughlin@cubist.com

65 Hayden Avenue p. 781.860.8660 Lexington, MA 02421
  • Home
  • About
    Cubist
  • Products &
    Pipeline
  • Investor
    Relations
  • Careers
  • News &
    Media
  • Search
  • Privacy
    Policy